Know Labs to Present at the American Diabetes Association''s Scientific Sessions https://www.investing.com/news/press-releases/know-labs-to-present-at-the-american-diabetes-associations-scientific-sessions-93CH-3492677
Know Labs to Present at the American Diabetes Association's Scientific Sessions SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostic technology, today announced further interim results from a clinical research study that assessed the accuracy of Know Labs' proprietary non-invasive radiofrequency (RF) dielectric sensor in measuring blood glucose. Participants with prediabetes and Type 2 diabetes were studied and venous blood was used as a comparative reference. The study found that the accuracy of Know Labs'.
Know Labs Joins the Industrial Participant Program of the Wyss Institute for Biologically Inspired Engineering at Harvard University https://www.investing.com/news/press-releases/know-labs-joins-the-industrial-participant-program-of-the-wyss-institute-for-biologically-inspired-engineering-at-harvard-university-93CH-3471730
Know Labs Joins the Industrial Participant Program of the Wyss Institute for Biologically Inspired Engineering at Harvard University SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostic technology, today announced that it has joined the Industrial Participant Program of the Wyss Institute for Biologically Inspired Engineering at Harvard University's Diagnostics Accelerator. The Wyss Institute at Harvard University is a translational research institute, developing disruptive innovation for healthcare and sustainability, powered by a multidisciplinary bioenginee.
Earnings call: Know Labs bolsters R&D for non-invasive glucose monitor https://www.investing.com/news/stock-market-news/earnings-call-know-labs-bolsters-rd-for-noninvasive-glucose-monitor-93CH-3444489
Know Labs Appoints Chris Somogyi as President, International SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging leader in non-invasive medical diagnostic technology, today announced the appointment of Chris Somogyi as President, International. With over 40 years of experience in commercializing innovation across related industries, Somogyi brings a wealth of expertise to lead the Company's “Skunkworks” Program and global patent licensing efforts. In his role, Somogyi will focus on identifying new applications of Know Labs' extens.
KNW Stock Earnings: Know Labs Misses EPS for Q2 2024 Know Labs (NYSEMKT: KNW ) just reported results for the second quarter of 2024. Know Labs reported earnings per share of -7 cents. This was below the analyst estimate for EPS of -2 cents. The company did not report any revenue for the quarter. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. Legendary Investor Predicts: “Forget A.I. THIS Technology Is the Future” The post KNW Stock Earnings: Know Labs Misses EPS for Q2 2024 appeared first on InvestorPlace .
Know Labs, Inc. (KNW) Q2 2024 Earnings Call Transcript Know Labs, Inc. (NYSE:KNW ) Q2 2024 Earnings Conference Call May 15, 2024 4:30 PM ET Company Participants Jordyn Hujar - Chief of Staff Ron Erickson - Chief Executive Officer Peter Conley - Chief Financial Officer Conference Call Participants Operator Greetings. Welcome to Know Labs's Second Quarter 2024 Earnings Conference Call.
Know Labs, Inc. Reports Second Quarter FY 2024 Results SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostic technology, today reported financial results for the second quarter of the fiscal year 2024 ended March 31, 2024. Financial Highlights: In Q2 FY 2024, Know Labs reported an operating loss of $4.73 million dollars, compared to an operating loss of $4.81 million dollars in Q2 FY 2023, a reduction in operating loss of 1.7%. This translates to Earnings Per Share of a loss of $0.07,.